Journal
THERANOSTICS
Volume 2, Issue 2, Pages 156-178Publisher
IVYSPRING INT PUBL
DOI: 10.7150/thno.4068
Keywords
Protease; activatable probe; Alzheimer's disease; cancer; caspase; cathepsin; kallikrein; MMP; PSA; serine protease; aspartyl protease
Categories
Funding
- National Institutes of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH)
- NIH [K99/R00]
Ask authors/readers for more resources
In this extensive review, we elucidate the importance of proteases and their role in drug development in various diseases with an emphasis on cancer. First, key proteases are introduced along with their function in disease progression. Next, we link these proteases as targets for the development of prodrugs and provide clinical examples of protease-activatable prodrugs. Finally, we provide significant design considerations needed for the development of the next generation protease-targeted and protease-activatable prodrugs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
